Results of the Randomised Phase III PACE B Trial - Comparing Standard Fractionation & Stereotactic Body Radiotherapy
A session from the Radiosurgery Society 2019 Webinar Series presented by:
Alison Tree, BSc, MBBS, FRCR, MD(Res)
Debra Freeman, MD
This course, which has been accredited by the American Board of Radiology (ABR) for Self-Assessment Module (SAM) maintenance of certification credit for both physicians and medical physicists, is available from August 19, 2019, through 11:59 p.m. Eastern time on August 18, 2022.
In order to earn credit for this course, participants must:
Learners must listen to each self-directed audio recording while following along with the visual slides.
Pass the post-test with a score of 75% or higher.
Complete an evaluation form to receive a certificate of completion.
Participate in the entire activity as partial credit is not available.
If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
According to the American Cancer Society, prostate cancer is the 2nd most common type of cancer in men (behind skin cancer), with nearly 175,000 new cases in the U.S. each year resulting in about 31,600 deaths. Approximately 1 of every 9 men will be affected by this cancer during his lifetime. The most common type of treatment for prostate cancer is surgery or external beam radiation therapy (EBRT) or a combination of the two. However, some studies have shown stereotactic body radiation therapy (SBRT) treatment for low and favorable intermediate risk prostate cancer to be effective in over 95% of the cases treated at 5 years with a very low toxicity profile. These early study results have necessitated the need for further study. The Pace B trial was created to compare low and intermediate risk prostate cancer cases in a randomized fashion both for patients that were surgical candidates (surgery vs. SBRT) and non-surgical candidates (SBRT vs. EBRT).
This program is designed to meet the needs of radiation oncologists, neurosurgeons, medical physicists, residents-in-training and healthcare professionals with interest in learning about the PACE trial.
Understand the PACE trial and the data it will be reporting now and in the future.
Learn about the toxicity profile of SBRT and standard radiotherapy in a randomised setting.
Set this in context of the current data.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Radiosurgery Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
Amedco LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Radiology SA-CME Self-Assessment Credit
The Radiosurgery Society Self-Assessment Module (SAM) titled Results of the Randomised Phase III PACE B Trial - Comparing Standard Fractionation & Stereotactic Body Radiotherapy is qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program and has been qualified for 1.0 SAM credits. The ABR qualified this SAM on August 19, 2019.
Physicists: Please note that AMA Category 1 CE offerings count towards ARB-MOC credits. The Radiosurgery Society does not offer CAMPEP credit for our Self-Assessment Modules (SAMs).
For more information, please refer to the ABR information guide found here.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
Alison Tree, BSc, MBBS, FRCR, MD(Res) - Elekta: Research Grant Site Principal Investigator & Speakers Bureau; MSD: Research Grant Site Principal Investigator; Ferring: Speakers Bureau; Janssen: Speakers Bureau; Astellas: Other
Debra Freeman, MD - No Disclosures
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Certificate of Participation
A certificate will be issued upon completion of course requirements, including the evaluation, enabling you to register your credit with the appropriate licensing boards or associations.
A browser version of Internet Explorer 10.0 and higher or Firefox 3.0 or higher, Google Chrome Version 35 or higher.
A note on browser incompatibility:
We have tested IE 6.x in controlled configurations and we can stream successfully, but there are some versions that may not support the RTMP streams we push out - basically new technology that old technology can't handle.
Possible remedy: upgrade browser version, try alternate browsers such as Firefox.
Flash Player Version 11 or higher. If you have an older version it would be best to upgrade now. It's free and does not require a reboot. http://get.adobe.com/flashplayer
Windows Based Computer, Mac based Computers, smart phone, tablets
Windows Based Computer, Mac based Computers, smart phone, tablets
Windows XP SP 3 or Vista Home Premium or better
Mac OS x 10.5.3 or better
Pentium 4 or better
1meg of System Ram (Memory)
True Color 32 bit video card
Sound card and speakers
For more help with technical issues please click here.
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed on the RSS website under the title of the course.
Participants using RSS online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the RSS website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. The RSS reserves the right to remove a course before the end of its qualification period.